Sigma Healthcare Limited (SIG.AX) Stock Analysis
Free AI-powered analysis and research for Sigma Healthcare Limited stock
Sector: Healthcare
SIG.AX snapshot
Data as of 4 Nov 2026 close. Updated daily.
Sigma Healthcare Limited scores 52/100 on StockIQ's model, which reads as mixed signals overall. The price is below its 200-day average and at 44% of its 52-week range, down 10.0% over the past year. Latest reported figures show a profit margin of 6.5%, return on equity of 14.7% and revenue growth of +31.9%.
What is driving the score
- Strong Uptrend: +10
- MACD Bullish: +8
- High P/E (45.6): -10
- Strong Revenue Growth (31.9%): +8
- High P/B (6.30): -5
- Below MA200: -4
- Underperforming (-10.0% over 1 year): -5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full SIG.AX report
Sigma Healthcare Limited (SIG.AX) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze SIG.AX Now βπ° Latest Update
Sigma Healthcare Ltd (SIGGF) (FY 2026) Earnings Call Highlights: Revenue Surges 15.5% to $10. ...
Thu, August 27, 2026 at 7:01 AM UTC 3 min read
Sigma Healthcare Ltd (SIG.AX) reported a 15.5% increase in revenue, reaching $10 million for FY 2026, during its recent earnings call. This significant growth highlights the company's strong performance and potential for continued expansion in the healthcare sector. Investors may view this positive trend as a signal of robust operational efficiency and market demand, potentially enhancing the company's attractiveness in the competitive landscape.